Ngā hua rapu - David Steffin
- E whakaatu ana i te 1 - 2 hua o te 2
-
1
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs mā David Steffin, Ibrahim N. Muhsen, LaQuisa C. Hill, Carlos A. Ramos, Nabil Ahmed, Meenakshi Hegde, Tao Wang, Meng-Fen Wu, Stephen Gottschalk, Sarah Burkhead Whittle, Premal Lulla, Maksim Mamonkin, Bilal Omer, Rayne H. Rouce, Andras Heczey, Leonid S. Metelitsa, Bambi Grilley, Catherine Robertson, Virginia Torrano, Natalia Lapteva, Adrian P. Gee, Cliona M. Rooney, Malcolm K. Brenner, Helen E. Heslop
I whakaputaina 2022Artigo -
2
Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers mā Andras Heczey, David Steffin, Nisha Ghatwai, Antonino Montalbano, Purva Rathi, Amy N. Courtney, Azlann Arnett, Julien Fleurence, Ramy Sweidan, Tao Wang, Huimin Zhang, Prakash Masand, John M. Maris, Dan Martinez, Jennier Pogoriler, Navin Varadarajan, Sachin G. Thakkar, Deborah Lyon, Natasha Lapteva, Zhuyong Mei, Kalyani Patel, Dolores López‐Terrada, Carlos A. Ramos, Premal Lulla, Tannaz Armaghany, Bambi Grilley, Gianpietro Dotti, Leonid S. Metelitsa, Helen E. Heslop, Malcolm K. Brenner, Pavel Sumazin
I whakaputaina 2024Pré-impressão